A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma

Published:2019-04 Issue: Volume:111 Page:50-58
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Herd Fiona,Basta Nermine O.,McNally Richard J.Q.,Tweddle Deborah A.

Funder

North of England Children's Cancer Research (NECCR) Fund

Great North Children's Hospital

Masters of Clinical Research

Newcastle Hospital Charity and Cancer Research

Action Medical Research & Great Ormond Street Children's Charity

NECCR

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. The international neuroblastoma risk group (INRG) classification system: an INRG task force report;Cohn;J Clin Oncol,2009

2. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma;Basta;Br J Canc,2016

3. Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the international neuroblastoma risk group project;London;J Clin Oncol,2011

4. Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry;Garaventa;Eur J Cancer,2009

5. Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials;London;Cancer,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach;BMC Cancer;2024-09-12

2. Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial;Journal of Clinical Oncology;2024-04-01

3. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo;Drug Delivery and Translational Research;2023-12-31

4. Implications of Immunotherapy for Pediatric Malignancies: A Summary from the APSA Cancer Committee;Journal of Pediatric Surgery;2023-11

5. Histotripsy induces apoptosis and reduces hypoxia in a neuroblastoma xenograft model;International Journal of Hyperthermia;2023-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3